Provided by Tiger Trade Technology Pte. Ltd.

EyePoint

3.27
-0.1500-4.39%
Pre-market: 3.300.0334+1.02%07:01 EDT
Volume:3.44M
Turnover:11.40M
Market Cap:281.91M
PE:-0.87
High:3.46
Open:3.42
Low:3.25
Close:3.42
52wk High:19.11
52wk Low:3.25
Shares:86.21M
Float Shares:60.67M
Volume Ratio:1.38
T/O Rate:5.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7642
EPS(LYR):-3.1667
ROE:-148.70%
ROA:-74.85%
PB:1.69
PE(LYR):-1.03

Loading ...

EyePoint Pharmaceuticals Q1 net loss widens on increased R&D spending

Reuters
·
May 06

EyePoint Q1 FY26 net loss widens to $84.8 million; revenue drops to $0.7 million

Reuters
·
May 06

EyePoint Pharmaceuticals Q1 EPS $(0.99) Misses $(0.80) Estimate, Sales $696.000K Beat $352.833K Estimate

Benzinga Earnings
·
May 06

EyePoint Pharmaceuticals Q1 Basic EPS USD -0.99

THOMSON REUTERS
·
May 06

EyePoint Inc - Cash Position Expected to Fund Operations Into Q4 2027

THOMSON REUTERS
·
May 06

EyePoint Pharmaceuticals Q1 Net Income USD -84.832 Million

THOMSON REUTERS
·
May 06

EyePoint Pharmaceuticals Q1 Product Sales USD 467 Thousand

THOMSON REUTERS
·
May 06

EyePoint Pharmaceuticals Q1 Operating Expenses USD 87.922 Million

THOMSON REUTERS
·
May 06

EyePoint Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developments

GlobeNewswire
·
May 06

EyePoint schedules first-quarter results conference call and webcast

Reuters
·
Apr 29

EyePoint to Report First Quarter 2026 Financial Results on May 6, 2026

GlobeNewswire
·
Apr 29

Insiders Dump Shares in Global-e, EyePoint, Immunovant, Nerdy, Argan

TIPRANKS
·
Apr 25

Top Executive Makes Strategic Move With EyePoint Pharmaceuticals Stock

TIPRANKS
·
Apr 21

EyePoint Chief Medical Officer Ramiro Ribeiro disposes of 2,437 shares for $36,555

Reuters
·
Apr 21

BRIEF-Eyepoint Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 17

EyePoint grants inducement stock options for 362,500 shares to 14 new employees

Reuters
·
Apr 17

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 17

Assessing EyePoint (EYPT) Valuation After DURAVYU Phase 3 And Manufacturing Expansion Update

Simply Wall St.
·
Apr 15

EyePoint Highlights DURAVYU Phase 3 Progress and Cash Runway

TIPRANKS
·
Apr 14